Explore our latest articles, insights, and stories from the frontlines of clinical trials.
Stories from 2024–2025 trials show how wearable biosensor protocols, federated learning, teletriage, and digital phenotyping can make research humane—especially for parents of children with developmental disorders.
A stalled multicenter trial became a study in human-centered data: federated EHR analytics, governance playbooks, and predictive site-performance dashboards cut delays and taught trainees how research really works.
A patient's patch, a radiologist's AI nudge, and a blockchain-stamped consent: stories from 2024–2025 trials where wearables, AI breast biomarkers, eConsent, and mobile monitoring changed outcomes and trust.
A story of Maria, CHWs, and data-driven dashboards shows how teleconsent, mobile labs, and culturally tailored consent templates bring rural stroke trial access to multilingual patients.
Data-driven tactics for breast, stroke, and GLP-1 trials: community engagement, culturally tailored consent, and rural access solutions that put patients first and drive more representative enrollment.
Practical Q&A on adaptive monitoring, digital prescreening, and lean site modeling—plus patient stories and market insights to help teams handle seasonal recruitment surges effectively.
Practical Q&A on home asthma, COPD digital-monitoring, lung cancer immunotherapy, and post-COVID rehab trials—steps, caregiver tips, eligibility, and hopeful next steps.
Practical Q&A on GLP-1 impacts, seasonal enrollment tactics, patient-centric stroke design, and translating psilocybin research into care, with 2024-2025 insights and hope for patients.
An analytical look at how federated EHR analytics, synthetic control arms, bias-mitigation workflows, and MLOps combine to shorten timelines, protect patient outcomes, and train clinicians in modern trial science.
